In This Section
Issues & Advocacy
SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
LATEST NEWS
- November 22, 2022 —
CMS Publishes 2023 MPFS and Hospital OPPS Final Rule
On November 1, CMS released the 2023 Medicare Physician Fee Schedule and Hospital Outpatient Prospective payment Final Rules. - October 31, 2022 —
Mo-99/Tc-99m shortage expected to impact provider care and limit patient access
Nuclear Medicine Europe has reported a shortage of Molybdenum-99 (Mo-99)/Technetium-99m (T-99m). - September 13, 2022 —
The U.S. Departments of Health and Human Services (HHS), Labor, and the Treasury released final rules titled “Requirements Related to Surprise Billing: Final Rules.”
The U.S. Departments of Health and Human Services (HHS), Labor, and the Treasury released final rules titled “Requirements Related to Surprise Billing: Final Rules.” Read more for highlights of the updated rules. - August 14, 2022 —
The DOE Isotope Program Announces its Annual Medical Isotope User Group Meetings
In 2022, the Department of Energy (DOE) Isotope Program will host four virtual medical isotope user group meetings focused on the following emerging alpha and beta emitters: actinium-225, astatine-211, lead-212, and new this year, cerium-134. - August 4, 2022 —
SNMMI Urges Congress to Avert Cuts to Physician Reimbursement
Recently SNMMI—with more than 100 medical societies and various industry groups—espoused its support in two letters for averting cuts to the Medicare Physician Fee Schedule (MPFS) Proposed Rule. - July 14, 2022 —
CMS releases its CY 2023 Medicare Physician Fee Schedule Proposed Rule
The Centers for Medicare and Medicaid Services (CMS) released its 2023 Medicare Physician Fee Schedule (MPFS) Proposed Rule on July 7. - June 27, 2022 —
Aetna Reverses Cardiac PET/CT Non-Coverage & Updates Policy for PSMA Therapy
SNMMI and ASNC requested that Aetna reverse its non-coverage cardiac PET/CT policy. We are thrilled to communicate that within a few days of receiving our letter, Aetna reversed the policy. Also, Aetna recently updated and published their coverage policy for PSMA imaging for PLUVICTO therapy eligibility. - June 24, 2022 —
CMS Reopens NCD for Beta Amyloid PET in Dementia and Neurodegenerative Disease
On June 16, 2022, the Centers for Medicare and Medicaid Services (CMS) began a reconsideration process for its National Coverage Determination (NCD) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease
Click For More Government Relations News
Quicklinks
-
Tracy Lynn Faber Memorial Award
-
Edward J. Hoffman Award
-
Procedure Standards
The procedure standards will help to identify those elements of the ...